Detection of Sub-Clinical CWD Infection in Conventional Test-Negative Deer Long after Oral Exposure to Urine and Feces from CWD+ Deer by Haley, Nicholas J. et al.
Detection of Sub-Clinical CWD Infection in Conventional
Test-Negative Deer Long after Oral Exposure to Urine
and Feces from CWD+ Deer
Nicholas J. Haley
1, Candace K. Mathiason
1, Mark D. Zabel
1, Glenn C. Telling
2, Edward A. Hoover
1*
1Department of Microbiology, Immunology, and Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, Colorado,
United States of America, 2Department of Molecular Biology and Genetics, University of Kentucky, Lexington, Kentucky, United States of America
Abstract
Background: Chronic wasting disease (CWD) of cervids is a prion disease distinguished by high levels of transmissibility,
wherein bodily fluids and excretions are thought to play an important role. Using cervid bioassay and established CWD
detection methods, we have previously identified infectious prions in saliva and blood but not urine or feces of CWD+
donors. More recently, we identified very low concentrations of CWD prions in urine of deer by cervid PrP transgenic
(Tg[CerPrP]) mouse bioassay and serial protein misfolding cyclic amplification (sPMCA). This finding led us to examine
further our initial cervid bioassay experiments using sPMCA.
Objectives: We sought to investigate whether conventional test-negative deer, previously exposed orally to urine and feces
from CWD+ sources, may be harboring low level CWD infection not evident in the 19 month observation period. We further
attempted to determine the peripheral PrP
CWD distribution in these animals.
Methods: Various neural and lymphoid tissues from conventional test-negative deer were reanalyzed for CWD prions by
sPMCA and cervid transgenic mouse bioassay in parallel with appropriate tissue-matched positive and negative controls.
Results: PrP
CWD was detected in the tissues of orally exposed deer by both sPMCA and Tg[CerPrP] mouse bioassay; each
assay revealed very low levels of CWD prions previously undetectable by western blot, ELISA, or IHC. Serial PMCA analysis of
individual tissues identified that obex alone was positive in 4 of 5 urine/feces exposed deer. PrP
CWD was amplified from both
lymphoid and neural tissues of positive control deer but not from identical tissues of negative control deer.
Discussion: Detection of subclinical infection in deer orally exposed to urine and feces (1) suggests that a prolonged
subclinical state can exist, necessitating observation periods in excess of two years to detect CWD infection, and (2)
illustrates the sensitive and specific application of sPMCA in the diagnosis of low-level prion infection. Based on these
results, it is possible that low doses of prions, e.g. following oral exposure to urine and saliva of CWD-infected deer, bypass
significant amplification in the LRS, perhaps utilizing a neural conduit between the alimentary tract and CNS, as has been
demonstrated in some other prion diseases.
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Introduction
Chronic wasting disease (CWD) is an efficiently transmitted
prion disease of cervids (e.g. deer, elk, and moose), and is the only
known prion disease affecting free-ranging, non-domestic animals.
The origins of CWD are uncertain, but the disease has been
present in wild cervid populations of northern Colorado and
southern Wyoming for at least 40 years [1,2]. Since its discovery,
CWD has been identified in captive and free-ranging cervids in 15
states, 2 Canadian provinces, and Korea [3]. As surveillance
efforts have intensified, CWD has been detected in areas
previously thought to be free of infection, including recent
discoveries in West Virginia, New York, and Michigan [4,5,6].
The prevalence of CWD varies across North America, but can be
as high as 30% in some areas of Colorado or in captive
populations [7,8].
Although the mechanisms of CWD transmission are incom-
pletely understood, there is evidence inferring that infection is
transmitted horizontally via saliva and urine [9,10], and may be
acquired from the environment [11,12,13]. With the expanded
recognition of the disease across the continental United States, it is
also likely that substantial human exposure has occurred.
However, because of an apparently strong species barrier
[14,15] and the as yet incompletely understood natural routes
and kinetics of CWD transmission, the magnitude and conse-
quence of this exposure remain speculative.
While infectious CWD prions have been detected in saliva,
blood, urine, and feces (i.e. prionsialia, prionemia, prionuria, and
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blotting, immunohistochemistry, and enzyme-linked immunosor-
bent assay) have been unable to identify PrP
CWD in these materials
[9,10,16,17]. In the same vein, the early and antemortem
identification of subclinically infected individuals requires demon-
stration of PrP
CWD in biopsied lymphoreticular system (LRS)
tissues [18,19,20,21]. Improving the sensitivity of low level of
CWD prion detection in excreta or at early sites of accumulation,
may allow for earlier antemortem diagnosis and a stronger
estimate of prevalence [17,22,23,24,25], an approach which could
also aid in detection of human transmissible spongiform
encephalopathies (TSE’s).
Apart from inoculation of susceptible hosts (bioassay), only in
vitro amplification by serial protein misfolding amplification
(sPMCA) [17,26,27,28] offers the potential for comparable
sensitivity. Here we have employed both of the latter methods to
demonstrate low levels of infectious prions in clinically normal,
conventional assay-negative white-tailed deer orally exposed 19
months previously to urine and feces from CWD+ deer.
Materials and Methods
Ethics Statement
All animals were handled in strict accordance with good animal
practice as defined by relevant national and/or local animal
welfare bodies, and all animal work was approved by Colorado
State University Animal and Care Use Committee (ACUC
approval number 08-175A-01).
Infected Cervids
Five white-tailed deer (Odocoileus virginianus) were orally inocu-
lated with urine (50ml total volume) and feces (50g total volume)
from CWD+ donor deer. The deer were monitored for 19 months
post inoculation (pi), during which time they remained asymp-
tomatic. At 19 months pi, due to limitations in holding space
imposed by other ongoing studies, the animals were euthanized,
necropsied, and brain and lymphoid tissues examined for PrP
CWD
by western blotting (WB) and immunohistochemistry (IHC) [9].
The sources of the urine and feces used for inoculation were three
terminally-ill mule deer (Odocoileus hemionus) of unknown PrP
genotype. Three of the inoculated deer were homozygous for
glycine (i.e. G/G) at cervid PrP position 96 (Deer #’s 134, 141,
and 150), while two were heterozygous at that location (Deer #’s
111 and 124), with alleles encoding for both glycine and serine (G/
S). Tissues from all five animals were negative for PrP
CWD by WB
and IHC and the animals were thus considered CWD-negative.
The same tissue sets were collected from positive and negative
control animals, including a deer inoculated intracranially (IC)
with CWD+ brain (deer #106, G/S at position 96), two deer
inoculated per os (PO) with saliva from CWD+ deer (deer #113
and 122, both G/G at position 96) and three deer inoculated by
the IC and PO routes with brain homogenate from a CWD-naive
deer (deer # 103 and 123, both G/G at position 96 and deer
#4488 – G/S at this loci). Each deer was necropsied using fresh
necropsy instruments, and all tissue samples were frozen at 270uC
until use. All animals were maintained in accord with Colorado
State University IACUC guidelines.
Study Samples and Preparation
Obex, vagal nerve, intermediolateral spinal cord segments,
sections of ileum, and a number of lymphoid tissues, including
tonsil and retropharyngeal, mesenteric, mediastinal, and ileoceco-
colic lymph nodes, were collected at necropsy and frozen at
270uC. In initial sPMCA and bioassay experiments, obex and
retropharyngeal lymph node (RLN) tissues from individual
animals were pooled, as both these tissues have proven sensitive
in the identification of PrP
CWD at various stages of infection
[22,29,30,31,32,33]. In later serial PMCA (sPMCA) experiments,
specific neural and LRS tissues were analyzed individually. In each
case, a fifty milligram section of each tissue was washed twice in
phosphate-buffered saline (PBS), then homogenized and prepared
as a 1% solution (w/v) in PBS using a FastPrep
TM tissue
homogenizer for 40s at power setting 6.5. All tissues were
prepared in individual microcentrifuge tubes and homogenized
in parallel in the same machine concurrent with controls.
Cervid PrP Transgenic Mice
Tg[CerPrP] line 5037 (tg5037) mice were generated in the
Telling laboratory at the University of Kentucky [34]. These mice
express, both centrally and peripherally, an allelic variant of the
prion gene possessed by Rocky Mountain Elk (Cervus elaphus),
coding for glutamic acid at position 226 of the cervid prion
protein. All mice were screened at weaning for the presence of the
cervid PRNP transgene by conventional and real-time PCR. Mice
testing negative for PrP
CWD at the completion of bioassay studies
were rescreened to confirm the presence of cervid transgene. Mice
were inoculated and maintained in accord with Colorado State
University IACUC guidelines.
Serial Protein Misfolding Cyclic Amplification (sPMCA)
Tissue homogenates from CWD-exposed deer, negative by WB,
IHC, and ELISA, were assayed for PrP
CWD by sPMCA. In initial
experiments, CWD+ obex/RLN homogenate from a white-tailed
deer IC-inoculated with CWD+ brain (deer #106) was used as a
positive control, while tissue preparations from two sham-
inoculated deer (#103 and 123) and untreated tg5037 mice were
used as negative controls. In later experiments, a tissue set from a
deer orally inoculated with CWD+ brain (deer #148) was selected
for use as positive controls; negative control animals remained
unchanged. All test samples were prepared in parallel with tissue-
matched positive and negative controls as a 1% homogenate in
PBS as described above and subsequently spiked into normal brain
homogenate for amplification as described previously [17,28,35].
Normal brain homogenate (NBH), the substrate for prion
conversion in vitro, was prepared from tg5037 mice in a room
that had not previously been used for prion research. Following
euthanasia and perfusion with 5mM EDTA in phosphate-buffered
saline (PBS), whole brain was collected from naı ¨ve tg5037 mice
and placed on ice. Brain homogenates were prepared as a 10%
(w/v) solution in PMCA buffer (1% triton-X 100 [v/v], 5mM
EDTA, and 150mM NaCl in PBS adjusted to a pH of 7.2) with the
addition of Complete Protease Inhibitors (Roche Pharmaceuticals,
Indianapolis, IN) using a dounce homogenizer. Homogenates
were then centrifuged for 1 minute at 2000rpm and the
supernatant frozen in single-experiment aliquots at 270uCi na
‘‘prion-free’’ room until use in PMCA. Fifteen ml of test or control
tissue homogenate was added to 45ml of NBH and assayed, in
parallel and in adjacent wells of a 96-well plate (USA Scientific,
Ocala, FL); along with normal brain homogenate prepared from
unexposed tg5037 mice as additional, unseeded negative controls.
Plates were then sonicated using an ultrasonic processor (Misonix,
Farmingdale, NY) and incubated at 37uC. Sonication parameters
were set at 40s bursts at power level 7.0, followed by 30 minutes of
incubation. Ninety six cycles of sonication were performed over
48 hours, with a 10ml aliquot transferred to 50ml of fresh NBH for
serial amplification. Following three rounds of amplification,
samples were evaluated by western blotting, as described below,
for the presence of PrP
CWD. Brain homogenates from all mice
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CWD in bioassay experiments were likewise
analyzed to increase detection sensitivity. In analysis of individual
cervid tissue samples, occasional differences were noted in the
round in which amplification was initially observed. For this
reason, we tallied the number of successive positive rounds for
each sample in each repetition for semi-quantitative analysis. Over
the course of sPMCA experiments, multiple NBH preparations
were used, and each test or control sample was evaluated at least
three times for repeated verification of results.
Mouse Bioassays
Four groups of tg5037 mice (n=8/group) were anesthetized
with ketamine and xylazine and inoculated intracerebrally into the
left parietal lobe with 30ml of 1% obex/RLN homogenate. Positive
control mice were inoculated with obex and RLN from a deer IC-
inoculated with CWD+ brain (deer #106), while a single negative
control group was inoculated with combined obex and RLN
homogenates from two sham-inoculated deer (deer #103 and
123). Obex and RLN homogenates from two deer orally
inoculated with urine and feces (deer #134 and 150) were
selected for bioassay experiments based on their apparent
amplification ability in sPMCA experiments (below). Incubation
time was defined as the number of days from inoculation to the
onset of clinical signs of transmissible spongiform encephalopathy
(TSE), as previously described [36]. Animals were euthanized
when either signs of clinical TSE or distress were evident. Brain
harvested at necropsy was divided longitudinally, with one hemi-
section prepared for evaluation by western blotting and sPMCA
and the remaining hemi-section fixed in 10% neutral-buffered
formalin for immunohistochemical analysis
Western Blotting (WB)
Brain hemi-sections for WB and sPMCA were initially prepared
as a 10% (w/v) solution in PMCA buffer. Eleven ml of sample
homogenate were mixed with 7ml of sample buffer (0.1% [v/v]
triton-X 100 and 4%(w/v) SDS in PBS) and digested with 2ml
proteinase-K at 500mg/ml (final concentration: 50mg/ml) for 209
at 37uC followed by 109 at 45uC. Seven mlo f4 6running buffer
were then added to the sample, followed by denaturation for 59 at
95uC. Twenty ml of this preparation were run on a pre-cast 12%
SDS-PAGE gel (Invitrogen) in a Bio-Rad electrophoresis appara-
tus for 2 hours at 120mV. Samples were then transferred to a
PVDF membrane (Millipore) for 1 hour at 110mV in a Bio-Rad
transfer apparatus. PVDF membranes were subsequently blocked
for 1 hour in 5%(w/v) powdered milk in 0.2% Tween-20 in tris-
buffered saline (TBST), followed by application of the primary
antibody, BAR224-HRP, diluted 1:20,000 in TBST with 5%
powdered milk, for 1 hour. Following washing, immunoreactivity
was detected using an enhanced chemiluminescent detection
system (ECL-plus, Amersham Biosciences) in a LAS 3000 imaging
system. (Fuji Photo Film, Fuji Inc, Valhalla, NY)
Neuropathology and Immunohistochemistry (IHC)
Brain hemi-sections were fixed in formalin overnight, treated
with 88% formic acid for one hour, washed in tap water and then
stored in 60% ethanol prior to paraffinization. Paraffin-embedded
tissue sections (6mm) were mounted onto positively charged glass
slides, deparaffinized, and rehydrated through graded ethanol. To
enhance detection, tissues were subjected to Heat Induced Epitope
Retrieval (HIER) using an automated antigen-retrieval system
(Retriever
TM) and a proprietary buffer solution (DakoCytomation
Target Retrieval Solution, DAKO, Hamburg, Germany). Tissues
were then stained with an automated immunostainer, using
polyclonal PrP antibody R-505 as the primary antibody (a gift
from Dr. Jan Langeveld, Central Veterinary Institute of
Wageningen University), The Netherlands) at a 1:500 final
dilution, followed by secondary application of a universal anti-
rabbit polyclonal antibody conjugated to horseradish peroxidase
(HRP). Detection was completed using HRP-mediated hydrogen
peroxide immunostaining (AEC+, DAKO), with hematoxylin as a
counterstain.
Results
To evaluate CWD-exposed, yet IHC-, and WB-negative, deer
for subclinical CWD infection, we pooled obex and retropharyn-
geal lymph node (RLN) tissues in an effort to enhance detection
sensitivity. Pooled tissues from individual animals were initially
analyzed via serial PMCA (sPMCA) with results subsequently
confirmed in two of these individuals using bioassay in cervidized
tg5037 mice. Serial PMCA was then used to analyze individual
nervous and LRS tissues to estimate the mechanism of CNS
invasion in animals orally exposed to presumed low doses of CWD
prions that may be present in urine and feces.
Serial PMCA Amplification of PrP
CWD from Tissues of Deer
Orally Exposed to Urine and Feces
Obex and RLN tissues collected at necropsy from experimen-
tally exposed deer were prepared as a 1% solution in PBS and
subjected to three rounds of sPMCA as described. In our
experience, three rounds of amplification permits a 2000 to
4000-fold increase in sensitivity as compared to traditional western
blotting detection, while maintaining 100% specificity [17,28]. In
three independent experiments, obex and RLN homogenates from
individual deer that had been orally inoculated with urine and
feces from a CWD+ source (deer #’s 111, 124, 134, 141 and 150)
consistently amplified PrP
CWD by sPMCA. Positive control tissues
from an IC-inoculated deer (deer #106) also successfully amplified
PrP
CWD through each round, while concurrently run control tissue
homogenates from CWD-negative brain-inoculated deer (deer #’s
103 and 123) or naı ¨ve tg5037 mice were negative by sPMCA.
(Figure 1)
Based on these findings, tissues from two white-tailed deer with
the greatest apparent in vitro amplification ability (deer #134 and
#150, Fig. 1), along with tissue-matched controls, were selected
for further evaluation by tg5037 mouse bioassay. Groups of mice
were inoculated with obex/RLN homogenates, monitored for
clinical signs of prion infection, and euthanized when terminal
disease was apparent. Brains from inoculated mice were evaluated
for PrP
CWD by WB, IHC and, when negative by these assays, also
by sPMCA.
Authentic Prion Infectivity Identified in tg5037 Mouse
Bioassay
In a group of 8 mice inoculated with obex/RLN homogenates
from deer #134, 7 of the 8 mice developed clinical signs consistent
with TSE, including progressive ataxia and weight loss, by 264
days post inoculation (dpi). WB and IHC confirmed the presence
of PrP
CWD in each of these seven mice. The remaining mouse in
this group died of intercurrent disease at 161 dpi. This mouse
showed no evidence of clinical TSE and was negative for PrP
CWD
by both IHC and WB. (Fig. 2, mouse #2-B) In a second group of
mice, inoculated with tissues from deer #150, 8 of 8 mice
developed similar clinical signs of TSE infection and were
confirmed PrP
CWD-positive by WB and IHC by 272 dpi. All
mice inoculated with brain and RLN homogenates from positive
control deer #106 developed clinical TSE and were PrP
CWD-
positive by 173 dpi, whereas negative control mice remained
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negative for PrP
CWD by WB and IHC. (Fig. 3 and Table 1)
Biochemical Confirmation of Bioassay
Western blot glycoform patterns were typical of CWD in
Tg[CerPrP] tg5037 mice, spanning 21–27 kD following protein-
ase-K digestion and dominated by a di-glycosylated PrP
CWD
isoform. Representative WB’s from each group are shown in
Figure 2. Immunohistochemistry demonstrated a relatively narrow
distribution of PrP
CWD within the hippocampus of affected mice,
colocalizing with vacuolization and spongiform degeneration of
the neuropil. There was no apparent relationship between
deposition pattern, lesion intensity, and source inoculum. (Fig. 4)
Serial PMCA Identification of PrP
CWD in an Asymptomatic
Mouse
Negative control mice and a single test mouse expiring with
intercurrent disease at 161dpi, all of which were found negative for
Figure 1. Serial PMCA amplification of CWD prions in WB and IHC negative deer. Conventionally negative tissues from deer orally exposed
to urine and feces from CWD+ sources (Deer #’s 111, 124, 134, 141, and 150, lanes 4–8) amplified PrP
CWD after 2–3 rounds of PMCA, as did positive
control tissues from deer #106 (lane 1). Tissue samples from two sham-inoculated deer (#103 and 123, lanes 2 and 3) and two untreated tg5037 mice
(lanes 9 and 10) failed to amplify PrP
CWD in three rounds of sPMCA.
doi:10.1371/journal.pone.0007990.g001
Figure 2. Tg5037 mouse bioassay results. Kaplan-Meyer curve demonstrating prolonged incubation periods in mice inoculated with tissues from
deer #134 and 150 as compared to mice inoculated with tissues from deer testing positive by conventional assays.
doi:10.1371/journal.pone.0007990.g002
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CWD by WB and IHC, were further evaluated using sPMCA
over three rounds of amplification. In three repeated sPMCA
experiments, a subclinical prion infection was confirmed in the
remaining mouse inoculated with tissue from deer #134 (mouse
#Tg 2-B). None of the brains from mice inoculated with negative
control tissues amplified PrP
CWD, while positive control mice
amplified PrP
CWD successfully over three rounds. (Fig. 5)
Analysis of Individual Neural and Lymphoid Tissues by
sPMCA
To further examine the terminal distribution of CWD prions
following oral exposure to presumed low concentrations of
infectious prions in excreta, we analyzed individual tissue samples
from control and test deer using sPMCA. Positive control tissues in
these experiments were from two deer inoculated PO with saliva
from CWD+ deer (deer #113 and 122), while identical tissue sets
were collected from negative control deer #103, 123, and 4488. By
analyzing obex and retropharyngeal tissues individually, PrP
CWD
amplification was found to occur exclusively in obex preparations
from study animals. The levels of amplification observed were
compared to serial dilutions of positive control tissue, and correlated
to an approximately 20–40 fold dilution of 1% homogenate of deer
#106 obex in NBH (data not shown). These results were surprising
given that it has been reported that PrP
CWD is commonly found to
accumulate in the retropharyngeal lymph node, and other lymph
nodes of the alimentary tract, prior to its appearance in the obex in
experimental oral [31] and natural CWD infections [8,30]. We
therefore sought to determine whether other lymphoid tissues were
correspondingly bypassed in these deer.
In an attempt to understand if a strictly neural route of CNS
invasion might have occurred, we performed sPMCA on the
mesenteric, mediastinal, and ileocecocolic lymph nodes, tonsils,
vagus nerve, intermediolateral spinal cord segments, and ileum
from the above 5 urine/feces exposed deer and from positive and
negative control deer. Surprisingly, while PrP
CWD was amplified
from a terminal tonsil biopsy of a single study deer, neither vagus
nerve, nor the retropharyngeal, mesenteric, mediastinal or
ileocecocolic lymph nodes were positive for PrP
CWD by sPMCA
in any of the deer orally exposed to urine and feces from CWD+
donors (Figure 6). As might be expected, protease-resistant prion
protein was amplified from both neural and lymphoid tissues from
the positive control deer, while no amplification was observed in
corresponding tissues from negative control deer or multiple
unseeded NBH controls examined concurrently and on the same
plate as positive samples.
Discussion
The salient feature of chronic wasting disease is its facile
transmission among captive and free-ranging cervids. We have
previously demonstrated infectious prions in the saliva and blood
using cervid bioassay [9,10]. However, we were unable to identify
PrP
CWD in the tissues of deer orally exposed to combined urine
and feces, even though our later studies employing Tg[CerPrP]
mouse bioassay demonstrated very low levels of prion infectivity
(surmised by long incubation/survival periods) in the urine of
some CWD+ deer [17]. In the current study, the enhanced
sensitivities of sPMCA and intracerebral inoculation of cervid PrP-
tg5037 mice have led us to conclude that at 19 months post
inoculation, low levels of amplifiable and infectious CWD prions
were in fact present in the brains of the exposed, yet asymptomatic
and conventional assay negative, deer from our original oral
bioassay studies [9,10], thereby inferring that low levels of prion
infectivity were present in the urine/feces inocula. Whether the
apparent low concentrations of prions amplifiable from the obex of
the urine/feces recipients could represent a persistent non-
pathogenic prion carrier state, or rather (perhaps more likely)
indicates that an observation period far exceeding 19 months
would be required to reveal ultimately pathogenic prion infections
in these animals, remains undetermined.
Our initial bioassay deer were inoculated with both urine and
feces, thus our present findings cannot identify the specific excreta
involved in CWD transmission. It seems likely, however, that both
excretamay play an important rolein the horizontal transmission of
CWD, given the later demonstration of prion infectivity in urine
[17] and feces [16] of CWD+ deer using transgenic mouse bioassay.
Further experiments, employing cervid bioassay of separated
excreta and sPMCA are underway to better answer this question.
In the initial sPMCA and bioassay experiments, to maximize use
of available tg5037 mice, we analyzed homogenates of combined
neural (obex) and lymphoreticular (LRS) tissues for the CWD prion
protein. Information on the pathogenesis of CWD indicated that,
following oral exposure, PrP
CWD is first detectable in lymphatic
tissues draining the alimentary tract, especially retropharyngeal
lymph node and Peyer’s patches [8,29,30,31,37]. Thereafter, it is
assumed that neural transport may be occur through anterograde
ascension via myenteric or LRS sympathetic and parasympathetic
neural networks to the central nervous system [37], paralleling the
pathogenesis of sheep scrapie [38,39]. Thus the earliest and most
prominent CNS PrP
CWD accumulation is in the dorsal motor
Figure 3. Western blot detection of PrP
CWD in mouse CNS
tissues. Except for a single mouse (mouse Tg 2-B, lane 4), all mice
inoculated with tissues from deer #134 and 150 succumbed to prion
disease (lanes 3–7), as did mice inoculated with CWD+ deer #106 (lanes
1 and 2). Mice inoculated with tissues from sham-inoculated deer
showed no evidence of PrP
CWD by western blot (lanes 8 and 9).
doi:10.1371/journal.pone.0007990.g003
Table 1. Summary of immunohistochemistry (IHC), western
blot (WB), and serial PMCA results and Tg5037 mouse bioassay
of combined obex/RLN homogenates.
Mouse Bioassay
Inoculum IHC +’s WB +’s sPMCA +’s Incubation Period
106 8/8 8/8 N/A 148 (11)
134 7/8 7/8 1/1 238 (23)
150 8/8 8/8 N/A 259 (8)
103/123 0/8 0/8 0/8 340+
Mean incubation periods with standard deviations in parentheses; numerators
indicate number of animals testing positive over total number tested. For
PMCA, only those animals testing negative by IHC and WB were assayed. N/A:
not assayed.
doi:10.1371/journal.pone.0007990.t001
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neural spread to peripheral sites. We were therefore surprised to
find that PrP
CWD amplification was restricted to the obex of 4 out of
5 urine/feces inoculated deer. As with any assay, there is the
potentialforsamplequalityorthepresenceofinhibitorstoaffecttest
results, thereby explaining the absence of detectable PrP
CWD in the
lymphoid tissues of urine and feces inoculated deer. However, the
abundant successful amplification of PrP
CWD in lymphoid tissues of
saliva-inoculated deer infers that a significant technical barrier to
PrP
CWD amplification from lymph node is unlikely to explain the
results. Thereby, we surmised that either CWD prions may have
bypassed amplification in the LRS of these deer or were no longer
present at detectable levels in the periphery. While these results are
in contrast to the current concept of CWD pathogenesis
[9,30,31,37], absence of LRS involvement has been observed in
natural cases of scrapie [41,42,43,44] and bovine spongiform
encephalopathy (BSE) of cattle and sheep [38,39,45,46]. In scrapie-
infected sheep, for example, the absence of scrapie amplification in
the LRS as a result of host PrP genotype, limited dose exposure,
tissue route/conduit, or prion strain selection are all supported by
available evidence [41,42,43,44], and may also be plausible in cases
of CWD. The deer included in our study were of two PrP genotypes
at position 96, expressing either G/G or G/S, both of which have
been shown to be LRS competent in the pathogenesis of CWD,
although slower pathogenesis has been linked to 96S [8,19]. In
naturally occurring cases of bovine spongiform encephalopathy, the
BSE prion seems to exclusively utilize autonomic neural pathways
forneuro-invasion,a definingcharacteristicofBSE[38,39,45,46].It
is possible that CWD strains may eventually be uncovered with
BSE-like phenotypes which could be selected for by low dose
exposure. Nevertheless, there have been no reports of PrP
CWD
detectionsolely inthe CNSofinfected deer. Thus theexactroute by
which CWD prions accessed the CNS of deer in the present study
remains unidentified.
Detection of CWD prions in the present study samples relied
heavily on sPMCA, with cervid transgenic mouse bioassay as a
confirmatory assay. Given the risk of spurious positive results
possible with multiple rounds of sPMCA, whether due to
‘‘spontaneous generation’’ or contamination [47,48,49], we took
great care to minimize this risk using approaches that parallel those
to reduce cross-contamination in nested PCR. These precautions
took two forms: avoiding cross-contamination during sample
collection and initial processing, and prevention of intra-experi-
mental cross-contamination. Animals were necropsied in order of
approximate level of infection (based on inoculation material and
known tonsil biopsy results), beginning with negative controls,
followed by animals exposed yet biopsy negative throughout the
study, and finally exposed, biopsy positive animals. Fresh necropsy
instruments were used for each necropsy, with the central nervous
system tissues removed at the completion of the necropsy. All study
and control samples were then prepared in parallel using identical
equipment and reagents. Normalbrain homogenate substrates were
Figure 4. Spongiform degeneration and PrP
CWD in the hippocampus of inoculated mice. Vacuolated neurons and spongiform
degeneration of the neuropil characteristic of TSE demonstrated by H&E staining and co-localization of PrP
CWD florid plaques in the hippocampus of
mice inoculated with tissues from urine and feces exposed and positive control deer. Brains of mice inoculated with tissues from sham-inoculated
deer showed no evidence of spongiform degeneration or PrP
CWD immunostaining. Anti-prion polyclonal antibody R-505 was used as the primary
antibody. (Measure bar, 50 mm)
doi:10.1371/journal.pone.0007990.g004
Figure 5. Serial PMCA detection of CWD prions in inoculated
mice. Brain from a single tg5037 mouse (mouse Tg 2-B) was WB and
IHC negative yet amplified PrP
CWD after three rounds of sPMCA (lane 2),
as did a positive control mouse (lane 1). Mice inoculated with tissues
from sham-inoculated deer failed to amplify PrP
CWD (lanes 3 and 4).
doi:10.1371/journal.pone.0007990.g005
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prion study using disposable or sterilized equipment. Negative
controls included multiple samples from both sham-inoculated
cervids and uninfected Tg[CerPrP]-tg5037 mice. In addition, the
number of amplification rounds was limited to three to help ensure
specificity. Perhaps most importantly, the positive sPMCA results
identified in brainand lymph node homogenates wereconfirmed by
bioassay to provide support the conclusion that the sPMCA+ tissues
did in fact harbor infectious prions.
In summary, we provide evidence for the presence of infectious
prions in the brains of conventional prion-assay-negative deer orally
exposed 19 months earlier to urine and feces from CWD-infected
donor deer. This apparent low level of prion infection was amplified
bysPMCA,confirmed byTg[CerPrP] mouse bioassay, and detected
only in the obex region of the brain. These results demonstrate the
potential for CWD prion transmission via urine and/or feces, and
highlight the application of more sensitive assays such as sPMCA in
identification of CWD infection, pathogenesis, and prevalence.
Acknowledgments
The authors would like to sincerely thank David Osborne and Sally
Dahmes, Carl Miller and Robert Warren and the Warnell School of
Forestry, University of Georgia, without whom the primary experiments in
cervids could not have been performed. We thank Dr. Michael Miller of
the Colorado Division of Wildlife, who provided initial samples of CWD+
brain and bodily fluids. Timothy Kurt provided much valued assistance
with assay development and interpretation. For excellent long term care
and sample collection from source deer and transgenic mice, we thank
Sheila Hays and Jeanette Hayes-Klug. For her vital contribution to
developing the Tg[CerPrP] mice used in these studies we thank Tanya
Seward at the University of Kentucky. Finally, we thank the reviewers for
providing important criticisms to improve this manuscript.
Author Contributions
Conceived and designed the experiments: NJH EAH. Performed the
experiments: NJH. Analyzed the data: NJH CKM MDZ GCT EAH.
Contributed reagents/materials/analysis tools: NJH CKM MDZ GCT
EAH. Wrote the paper: NJH EAH.
References
1. Williams ES, Young S (1980) Chronic wasting disease of captive mule deer: a
spongiform encephalopathy. J Wildl Dis 16: 89–98.
2. Williams ES, Young S (1982) Spongiform encephalopathy of Rocky Mountain
elk. J Wildl Dis 18: 465–471.
3. Sigurdson CJ (2008) A prion disease of cervids: chronic wasting disease. Vet Res
39: 41.
4. http://www.wvdnr.gov/2005news/05news167.shtm: Chronic Wasting Disease
Found in Hampshire County Deer. Date Accessed: November 4
th,
2009.
5. http://www.agmkt.state.ny.us/AD/release.asp?ReleaseID=1420: POSITIVE
CASE OF CWD FOUND IN ONEIDA COUNTY DEER. Date Accessed:
November 4
th, 2009.
6. http://www.michigan.gov/dnr/0,1607,7-153-198865-,00.html Michigan’s First
Case of Chronic Wasting Disease Detected at Kent County Deer Breeding
Facility. Date Accessed: November 4
th, 2009.
7. Williams ES (2005) Chronic wasting disease. Vet Pathol 42: 530–549.
8. Keane DP, Barr DJ, Bochsler PN, Hall SM, Gidlewski T, et al. (2008) Chronic
wasting disease in a Wisconsin white-tailed deer farm. J Vet Diagn Invest 20:
698–703.
9. Mathiason CK, Powers JG, Dahmes SJ, Osborn DA, Miller KV, et al. (2006)
Infectious prions in the saliva and blood of deer with chronic wasting disease.
Science 314: 133–136.
10. Mathiason CK, Hays SA, Powers J, Hayes-Klug J, Langenberg J, et al. (2009)
Infectious Prions in Pre-Clinical Deer and Transmission of Chronic Wasting
Figure 6. Serial PMCA detection or PrP
CWD of neural and lymphoid tissues of deer exposed orally to urine and feces of CWD-
positive deer. For each tissue, the number of sPMCA rounds producing a positive result was tabulated for three independent experiments of three
rounds each. Samples appearing as positive in round 2 continued to be positive in round 3, and thus over the course of three experiments, were
positive a total of 6 out of 9 rounds (e.g. obex samples from deer 134 and 150). Samples becoming positive in the first round were succeeded by
positivity in rounds 2 and 3, and thus were positive in 9 out of 9 rounds (e.g. tonsil and RLN samples from deer 122 and 113). As would be expected,
the greatest number of positive results was observed in the positive control tissues, with some variance among tissues and between animals. Deer
orally exposed to urine and feces demonstrated PrP
CWD amplification almost exclusively from the obex; the terminal tonsil collection from a single
animal also was positive. By contrast, negative control tissues failed to amplify PrP
CWD. RLN: retropharyngeal lymph node; MedLN: mediastinal lymph
node; MesLN: mesenteric lymph node; ILN: ileocecocolic lymph node; IMLT: Intermediolateral spinal cord tract; SU: sample unavailable.
doi:10.1371/journal.pone.0007990.g006
Detection of Sub-Clinical CWD
PLoS ONE | www.plosone.org 7 November 2009 | Volume 4 | Issue 11 | e7990Disease Solely by Environmental Exposure. PLoS ONE 4:
e5916.
11. Miller MW, Williams ES, Hobbs NT, Wolfe LL (2004) Environmental sources
of prion transmission in mule deer. Emerg Infect Dis 10: 1003–1006.
12. Johnson CJ, Phillips KE, Schramm PT, McKenzie D, Aiken JM, et al. (2006)
Prions adhere to soil minerals and remain infectious. PLoS Pathog 2: e32.
13. Johnson CJ, Pedersen JA, Chappell RJ, McKenzie D, Aiken JM (2007) Oral
Transmissibility of Prion Disease Is Enhanced by Binding to Soil Particles. PLoS
Pathog 3: e93.
14. Kong Q, Huang S, Zou W, Vanegas D, Wang M, et al. (2005) Chronic wasting
disease of elk: transmissibility to humans examined by transgenic mouse models.
J Neurosci 25: 7944–7949.
15. Raymond GJ, Bossers A, Raymond LD, O’Rourke KI, McHolland LE, et al.
(2000) Evidence of a molecular barrier limiting susceptibility of humans, cattle
and sheep to chronic wasting disease. EMBO J 19: 4425–4430.
16. Tamguney G, Miller MW, Wolfe LL, Sirochman TM, Glidden DV, et al. (2009)
Asymptomatic deer excrete infectious prions in faeces. Nature 461: 529–532.
17. Haley NJ, Seelig DM, Zabel MD, Telling GC, Hoover EA (2009) Detection of
CWD prions in urine and saliva of deer by transgenic mouse bioassay. PLoS
ONE 4: e4848.
18. Spraker TR, Gidlewski TL, Balachandran A, VerCauteren KC, Creekmore L,
et al. (2006) Detection of PrP(CWD) in postmortem rectal lymphoid tissues in
Rocky Mountain elk (Cervus elaphus nelsoni) infected with chronic wasting
disease. J Vet Diagn Invest 18: 553–557.
19. Wolfe LL, Spraker TR, Gonzalez L, Dagleish MP, Sirochman TM, et al. (2007)
PrPCWD in rectal lymphoid tissue of deer (Odocoileus spp.). J Gen Virol 88:
2078–2082.
20. Wild MA, Spraker TR, Sigurdson CJ, O’Rourke KI, Miller MW (2002)
Preclinical diagnosis of chronic wasting disease in captive mule deer (Odocoileus
hemionus) and white-tailed deer (Odocoileus virginianus) using tonsillar biopsy.
J Gen Virol 83: 2629–2634.
21. O’Rourke KI, Zhuang D, Lyda A, Gomez G, Williams ES, et al. (2003)
Abundant PrP(CWD) in tonsil from mule deer with preclinical chronic wasting
disease. J Vet Diagn Invest 15: 320–323.
22. Spraker TR, Balachandran A, Zhuang D, O’Rourke KI (2004) Variable
patterns of distribution of PrP(CWD) in the obex and cranial lymphoid tissues of
Rocky Mountain elk (Cervus elaphus nelsoni) with subclinical chronic wasting
disease. Vet Rec 155: 295–302.
23. Castilla J, Gutierrez-Adan A, Brun A, Doyle D, Pintado B, et al. (2004)
Subclinical bovine spongiform encephalopathy infection in transgenic mice
expressing porcine prion protein. J Neurosci 24: 5063–5069.
24. Hill AF, Collinge J (2003) Subclinical prion infection in humans and animals. Br
Med Bull 66: 161–170.
25. Hill AF, Collinge J (2003) Subclinical prion infection. Trends Microbiol 11:
578–584.
26. Soto C, Saborio GP, Anderes L (2002) Cyclic amplification of protein
misfolding: application to prion-related disorders and beyond. Trends Neurosci
25: 390–394.
27. Saborio GP, Permanne B, Soto C (2001) Sensitive detection of pathological
prion protein by cyclic amplification of protein misfolding. Nature 411:
810–813.
28. Kurt TD, Perrott MR, Wilusz CJ, Wilusz J, Supattapone S, et al. (2007) Efficient
in vitro amplification of chronic wasting disease PrPRES. J Virol 81: 9605–9608.
29. Fox KA, Jewell JE, Williams ES, Miller MW (2006) Patterns of PrPCWD
accumulation during the course of chronic wasting disease infection in orally
inoculated mule deer (Odocoileus hemionus). J Gen Virol 87: 3451–3461.
30. Keane DP, Barr DJ, Keller JE, Hall SM, Langenberg JA, et al. (2008)
Comparison of retropharyngeal lymph node and obex region of the brainstem in
detection of chronic wasting disease in white-tailed deer (Odocoileus
virginianus). J Vet Diagn Invest 20: 58–60.
31. Sigurdson CJ, Williams ES, Miller MW, Spraker TR, O’Rourke KI, et al. (1999)
Oral transmission and early lymphoid tropism of chronic wasting disease PrPres
in mule deer fawns (Odocoileus hemionus). J Gen Virol 80(Pt 10): 2757–2764.
32. Race BL, Meade-White KD, Ward A, Jewell J, Miller MW, et al. (2007) Levels
of abnormal prion protein in deer and elk with chronic wasting disease. Emerg
Infect Dis 13: 824–830.
33. Hibler CP, Wilson KL, Spraker TR, Miller MW, Zink RR, et al. (2003) Field
validation and assessment of an enzyme-linked immunosorbent assay for
detecting chronic wasting disease in mule deer (Odocoileus hemionus), white-
tailed deer (Odocoileus virginianus), and Rocky Mountain elk (Cervus elaphus
nelsoni). J Vet Diagn Invest 15: 311–319.
34. Angers RC, Seward TS, Napier D, Green M, Hoover E, et al. (2009) Chronic
wasting disease prions in elk antler velvet. Emerg Infect Dis 15: 696–703.
35. Kurt TD, Telling GC, Zabel MD, Hoover EA (2009) Trans-species
amplification of PrP(CWD) and correlation with rigid loop 170N. Virology
387: 235–243.
36. Carlson GA, Kingsbury DT, Goodman PA, Coleman S, Marshall ST, et al.
(1986) Linkage of prion protein and scrapie incubation time genes. Cell 46:
503–511.
37. Sigurdson CJ, Spraker TR, Miller MW, Oesch B, Hoover EA (2001) PrP(CWD)
in the myenteric plexus, vagosympathetic trunk and endocrine glands of deer
with chronic wasting disease. J Gen Virol 82: 2327–2334.
38. van Keulen LJ, Bossers A, van Zijderveld F (2008) TSE pathogenesis in cattle
and sheep. Vet Res 39: 24.
39. Beekes M, McBride PA (2007) The spread of prions through the body in
naturally acquired transmissible spongiform encephalopathies. FEBS J 274:
588–605.
40. Peters J, Miller JM, Jenny AL, Peterson TL, Carmichael KP (2000)
Immunohistochemical diagnosis of chronic wasting disease in preclinically
affected elk from a captive herd. J Vet Diagn Invest 12: 579–582.
41. Jeffrey M, Begara-McGorum I, Clark S, Martin S, Clark J, et al. (2002)
Occurrence and distribution of infection-specific PrP in tissues of clinical scrapie
cases and cull sheep from scrapie-affected farms in Shetland. J Comp Pathol 127:
264–273.
42. Jeffrey M, Martin S, Thomson JR, Dingwall WS, Begara-McGorum I, et al.
(2001) Onset and distribution of tissue prp accumulation in scrapie-affected
suffolk sheep as demonstrated by sequential necropsies and tonsillar biopsies.
J Comp Pathol 125: 48–57.
43. Jeffrey M, Ryder S, Martin S, Hawkins SA, Terry L, et al. (2001) Oral
inoculation of sheep with the agent of bovine spongiform encephalopathy (BSE).
1. Onset and distribution of disease-specific PrP accumulation in brain and
viscera. J Comp Pathol 124: 280–289.
44. Siso S, Jeffrey M, Gonzalez L (2009) Neuroinvasion in sheep transmissible
spongiform encephalopathies: the role of the haematogenous route. Neuropathol
Appl Neurobiol 35: 232–246.
45. Wells GA (2003) Pathogenesis of BSE. Vet Res Commun 27 Suppl 1: 25–28.
46. Terry LA, Marsh S, Ryder SJ, Hawkins SA, Wells GA, et al. (2003) Detection of
disease-specific PrP in the distal ileum of cattle exposed orally to the agent of
bovine spongiform encephalopathy. Vet Rec 152: 387–392.
47. Agrimi U, Cosseddu G, Castilla J, Fernandez-Borges N, Di Bari MA, et al.
PMCA and Bank Voles: an Update; 2008 10/10/2008; Madrid, Spain.
48. Deleault NR, Harris BT, Rees JR, Supattapone S (2007) From the Cover:
Formation of native prions from minimal components in vitro. Proc Natl Acad
Sci U S A 104: 9741–9746.
49. Barria MA, Mukherjee A, Gonzalez-Romero D, Morales R, Soto C (2009) De
novo generation of infectious prions in vitro produces a new disease phenotype.
PLoS Pathog 5: e1000421.
Detection of Sub-Clinical CWD
PLoS ONE | www.plosone.org 8 November 2009 | Volume 4 | Issue 11 | e7990